X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALEMBIC LTD ALEMBIC PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 23.0 53.9 42.8% View Chart
P/BV x 6.1 3.0 199.2% View Chart
Dividend Yield % 0.8 0.4 210.8%  

Financials

 ALEMBIC PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
ALEMBIC LTD
Mar-16
ALEMBIC PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs79253 1,499.4%   
Low Rs44329 1,511.9%   
Sales per share (Unadj.) Rs167.04.7 3,538.8%  
Earnings per share (Unadj.) Rs38.28.8 435.0%  
Cash flow per share (Unadj.) Rs42.09.0 466.4%  
Dividends per share (Unadj.) Rs4.000.15 2,666.7%  
Dividend yield (eoy) %0.60.4 177.3%  
Book value per share (Unadj.) Rs84.927.7 306.2%  
Shares outstanding (eoy) m188.52267.03 70.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.78.7 42.5%   
Avg P/E ratio x16.24.7 345.8%  
P/CF ratio (eoy) x14.74.6 322.4%  
Price / Book Value ratio x7.31.5 491.1%  
Dividend payout %10.51.7 613.1%   
Avg Mkt Cap Rs m116,38310,962 1,061.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,214238 1,770.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,4871,260 2,498.4%  
Other income Rs m55264 20.9%   
Total revenues Rs m31,5421,524 2,069.6%   
Gross profit Rs m10,06083 12,149.5%  
Depreciation Rs m72261 1,176.1%   
Interest Rs m370 12,266.7%   
Profit before tax Rs m9,356285 3,284.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-22,096 -0.1%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m2,1606 35,413.1%   
Profit after tax Rs m7,1942,343 307.1%  
Gross profit margin %31.96.6 486.3%  
Effective tax rate %23.12.1 1,078.4%   
Net profit margin %22.8185.9 12.3%  
BALANCE SHEET DATA
Current assets Rs m15,0661,689 892.1%   
Current liabilities Rs m7,674486 1,578.4%   
Net working cap to sales %23.595.4 24.6%  
Current ratio x2.03.5 56.5%  
Inventory Days Days67217 30.9%  
Debtors Days Days4181 50.1%  
Net fixed assets Rs m8,2371,624 507.2%   
Share capital Rs m377534 70.6%   
"Free" reserves Rs m15,4165,960 258.7%   
Net worth Rs m16,0057,404 216.2%   
Long term debt Rs m0104 0.0%   
Total assets Rs m24,5948,010 307.0%  
Interest coverage x255.2950.7 26.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.2 813.7%   
Return on assets %29.429.3 100.5%  
Return on equity %44.931.6 142.1%  
Return on capital %58.731.3 187.5%  
Exports to sales %55.72.9 1,893.5%   
Imports to sales %10.428.9 36.1%   
Exports (fob) Rs m17,55137 47,306.7%   
Imports (cif) Rs m3,283364 902.7%   
Fx inflow Rs m17,81137 48,006.7%   
Fx outflow Rs m5,318365 1,457.2%   
Net fx Rs m12,493-328 -3,810.5%   
CASH FLOW
From Operations Rs m9,304346 2,692.1%  
From Investments Rs m-3,105-48 6,522.7%  
From Financial Activity Rs m-1,959-301 650.9%  
Net Cashflow Rs m4,240-3 -141,333.3%  

Share Holding

Indian Promoters % 74.1 64.0 115.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.2 1,450.0%  
FIIs % 9.1 9.7 93.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 26.1 53.3%  
Shareholders   49,328 54,701 90.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   NATCO PHARMA  PLETHICO PHARMA  WOCKHARDT LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jun 25, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS